Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
2010 · American Journal of Transplantation · 555 citations
https://doi.org/10.1111/j.1600-6143.2010.03016.x
T
Thomas C. Pearson
Emory Healthcare(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
350
Papers
21.0K
Citations
77
h-index
215
i10-index
Thomas C. Pearson is an academic researcher from Emory Healthcare. The author has contributed to research in topics: T-cell and B-cell Immunology & Myeloproliferative Neoplasms: Diagnosis and Treatment & Immune Cell Function and Interaction. The author has an h-index of 77, co-authored 298 publications.
ORCID: 0000-0002-4333-8453Papers by this author
worksRegulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.
1994 · The Journal of Immunology · 373 citations
https://doi.org/10.4049/jimmunol.152.11.5208
4-1BB Ligand, a Member of the TNF Family, Is Important for the Generation of Antiviral CD8 T Cell Responses
1999 · The Journal of Immunology · 260 citations
https://doi.org/10.4049/jimmunol.163.9.4859
IFN-γ Is Critical for Long-Term Allograft Survival Induced by Blocking the CD28 and CD40 Ligand T Cell Costimulation Pathways
1998 · The Journal of Immunology · 225 citations
https://doi.org/10.4049/jimmunol.160.5.2059
CD40-Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates
2011 · American Journal of Transplantation · 150 citations
https://doi.org/10.1111/j.1600-6143.2011.03509.x
CD40-CD40 Ligand Costimulation Is Required for Generating Antiviral CD4 T Cell Responses But Is Dispensable for CD8 T Cell Responses
1999 · The Journal of Immunology · 149 citations
https://doi.org/10.4049/jimmunol.163.6.3194
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat